As of 2025-12-19, the Relative Valuation of Biogen Inc (BIIB) is 204.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 169.91 USD, the upside of Biogen Inc based on Relative Valuation is 20.3%.
The range of the Relative Valuation is 178.54 - 255.97 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 18.0x | 17.0x |
| Forward P/E multiples | 17.9x - 22.0x | 19.1x |
| Fair Price | 178.54 - 255.97 | 204.43 |
| Upside | 5.1% - 50.6% | 20.3% |
| Date | P/E |
| 2025-12-17 | 15.69 |
| 2025-12-16 | 15.64 |
| 2025-12-15 | 16.03 |
| 2025-12-12 | 15.88 |
| 2025-12-11 | 15.73 |
| 2025-12-10 | 16.19 |
| 2025-12-09 | 16.03 |
| 2025-12-08 | 16.45 |
| 2025-12-05 | 16.53 |
| 2025-12-04 | 16.59 |
| 2025-12-03 | 16.48 |
| 2025-12-02 | 16.43 |
| 2025-12-01 | 16.21 |
| 2025-11-28 | 16.60 |
| 2025-11-26 | 16.59 |
| 2025-11-25 | 16.59 |
| 2025-11-24 | 16.12 |
| 2025-11-21 | 15.98 |
| 2025-11-20 | 15.34 |
| 2025-11-19 | 15.31 |
| 2025-11-18 | 15.39 |
| 2025-11-17 | 15.02 |
| 2025-11-14 | 15.28 |
| 2025-11-13 | 15.02 |
| 2025-11-12 | 14.72 |
| 2025-11-11 | 14.55 |
| 2025-11-10 | 14.25 |
| 2025-11-07 | 14.18 |
| 2025-11-06 | 14.29 |
| 2025-11-05 | 13.99 |
| 2025-11-04 | 13.62 |
| 2025-11-03 | 13.81 |
| 2025-10-31 | 14.07 |
| 2025-10-30 | 13.64 |
| 2025-10-29 | 13.48 |
| 2025-10-28 | 13.60 |
| 2025-10-27 | 13.72 |
| 2025-10-24 | 13.67 |
| 2025-10-23 | 13.69 |
| 2025-10-22 | 13.47 |
| 2025-10-21 | 13.33 |
| 2025-10-20 | 13.37 |
| 2025-10-17 | 13.04 |
| 2025-10-16 | 12.97 |
| 2025-10-15 | 13.10 |
| 2025-10-14 | 13.25 |
| 2025-10-13 | 13.19 |
| 2025-10-10 | 13.37 |
| 2025-10-09 | 13.64 |
| 2025-10-08 | 13.77 |